Biological therapy that uses antibodies against tumor necrosis factor α (anti-TNF-α) which leads to the quelling of inflammation of the intestinal mucosa, is currently recommended and the most effective therapy for severe IBD. This evidence concerns the gene TNF and inflammatory bowel disease.